Incorporating Target Shedding Into a Minimal PBPK–TMDD Model for Monoclonal Antibodies

Shedding of a pharmacological target from cells, giving rise to a soluble target that can also bind therapeutic proteins, is a common phenomenon. In this study, a minimal physiologically based pharmacokinetic model was used to simulate the pharmacokinetics of trastuzumab and the simultaneous binding...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, L, Gardner, I, Rose, R, Jamei, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910015/
https://www.ncbi.nlm.nih.gov/pubmed/24477089
http://dx.doi.org/10.1038/psp.2013.73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910015/
https://www.ncbi.nlm.nih.gov/pubmed/24477089
http://dx.doi.org/10.1038/psp.2013.73

Ejemplares similares